Stockscreener 앱 받기
73.39
0.09%
-0.045
전일 마감가:
$73.43
열려 있는:
$72.37
하루 거래량:
1.61M
Relative Volume:
0.31
시가총액:
$28.25B
수익:
$4.66B
순이익/손실:
$836.30M
주가수익비율:
35.06
EPS:
2.093
순현금흐름:
$1.08B
1주 성능:
+0.15%
1개월 성능:
+1.15%
6개월 성능:
-1.26%
1년 성능:
-16.98%
1일 변동 폭
$71.57
$73.44
1주일 범위
$70.81
$74.43
52주 변동 폭
$54.11
$89.98
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
73.39 | 28.26B | 4.66B | 836.30M | 1.08B | 2.093 |
|
ABT
Abbott Laboratories
|
114.60 | 202.32B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
387.58 | 148.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.40 | 125.38B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
76.24 | 114.04B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
87.02 | 50.18B | 6.07B | 1.06B | 799.60M | 1.8527 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
TD Asset Management Inc Buys 44,770 Shares of DexCom, Inc. $DXCM - MarketBeat
Quantbot Technologies LP Buys 92,273 Shares of DexCom, Inc. $DXCM - MarketBeat
Rafferty Asset Management LLC Grows Holdings in DexCom, Inc. $DXCM - MarketBeat
Erste Asset Management GmbH Has $1.66 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
Intech Investment Management LLC Sells 66,221 Shares of DexCom, Inc. $DXCM - MarketBeat
Allianz SE Sells 43,425 Shares of DexCom, Inc. $DXCM - MarketBeat
Handelsbanken Fonder AB Grows Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 53,341 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
DNB Asset Management AS Acquires 803,086 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Banco Santander S.A. - MarketBeat
DexCom (DXCM) Expands Board with New Appointment - GuruFocus
Dexcom Adds Google Executive Rick Osterloh to Board - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom appoints Google executive Rick Osterloh to board - Investing.com
Dexcom Appoints Rick Osterloh to Board of Directors - The Joplin Globe
Rick Osterloh of Google joins Dexcom (NASDAQ: DXCM) board effective Feb. 26 - Stock Titan
DexCom, Inc. Appoints Rick Osterloh to Board of Directors, Effective February 26, 2026 - marketscreener.com
Westfield Capital Management Co. LP Trims Stake in DexCom, Inc. $DXCM - MarketBeat
Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership - Insider Monkey
Fox Run Management L.L.C. Purchases Shares of 18,368 DexCom, Inc. $DXCM - MarketBeat
HighTower Advisors LLC Lowers Stake in DexCom, Inc. $DXCM - MarketBeat
DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals - Yahoo Finance
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Morningstar
Assessing DexCom (DXCM) Valuation After Short Term Gains And A 14.5% Undervaluation Narrative - simplywall.st
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars - The Globe and Mail
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars - The Motley Fool
Dexcom announces upcoming conference presentation - marketscreener.com
BTIG Research Reiterates Buy Rating for DexCom (NASDAQ:DXCM) - MarketBeat
Dexcom Announces Upcoming Conference Presentation - The Joplin Globe
Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat - Finviz
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
I Tried Dexcom’s Stelo Glucose Biosensor for 30 Days. Here’s What I Learned - Athletech News
I Tried Dexcom’s Stelo, a Glucose Biosensor, for 30 Days. Here’s What I Learned - Athletech News
DexCom: How Product Innovation and Feature Adoption Are Expanding Its Diabetes Opportunity! - Smartkarma
Dexcom’s CEO to Chair AdvaMed’s Diabetes Sector - Medical Product Outsourcing
DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership - Insider Monkey
DexCom, Inc. (DXCM): Investor Outlook Highlights 16.94% Upside Potential and Strong Buy Ratings - DirectorsTalk Interviews
DexCom Breaks Above 200-Day Moving AverageBullish for DXCM - Nasdaq
Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story? - Yahoo Finance
Public Sector Pension Investment Board Decreases Holdings in DexCom, Inc. $DXCM - MarketBeat
Is DexCom Inc. a strong growth stockJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - mfd.ru
DexCom, Inc. $DXCM Shares Bought by Premier Fund Managers Ltd - MarketBeat
Jupiter Asset Management Ltd. Takes Position in DexCom, Inc. $DXCM - MarketBeat
Aurora Investment Counsel Makes New $2.29 Million Investment in DexCom, Inc. $DXCM - MarketBeat
DexCom G7 Rollout And Expansion Shape Growth And Competitive Outlook - Sahm
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term - Yahoo Finance
King Luther Capital Management Corp Reduces Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
SENS Eversense 365 Integrated With twiist Gains Full Availability - TradingView
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 25,094 Shares of DexCom, Inc. $DXCM - MarketBeat
The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call - The Globe and Mail
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.66%
0.65%
자본화:
|
볼륨(24시간):